$PED
PEDEVCO CORP Stock $ped

$ped Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000165495422015283 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$5.925M	$7.472M	$4.069M
YoY Change	31.08%	83.63%	68.35%
Cost Of Revenue	$2.321M	$2.918M	$1.423M
YoY Change	30.47%	105.06%	35.01%
Gross Profit	$3.604M	$4.554M	$2.646M
YoY Change	31.48%	72.11%	94.13%
Gross Profit Margin	60.83%	60.95%	65.03%
Selling, General & Admin	$1.746M	$1.220M	$1.337M
YoY Change	-1.63%	-8.75%	4.37%
% of Gross Profit	48.45%	26.79%	50.53%
Research & Development			$0.00
YoY Change			-100.0%
% of Gross Profit			0.0%
Depreciation & Amortization	$4.726M	$2.313M	$1.666M
YoY Change	85.26%	38.84%	-43.98%
% of Gross Profit	131.13%	50.79%	62.96%
Operating Expenses	$6.472M	$6.451M	$4.426M
YoY Change	49.61%	45.75%	-16.65%
Operating Profit	-$2.868M	$1.021M	-$357.0K
YoY Change	80.95%	-385.99%	-87.66%
Interest Expense	$77.00K	$0.00	$0.00
YoY Change	1825.0%		-100.0%
% of Operating Profit		0.0%
Other Income/Expense, Net	$7.000K	$58.00K	$32.00K
YoY Change	-93.27%	81.25%	-94.67%
Pretax Income	-$2.784M	$1.079M	-$325.0K
YoY Change	88.49%	-432.0%	-85.83%
Income Tax
% Of Pretax Income
Net Earnings	-$2.784M	$1.079M	-$325.0K
YoY Change	88.49%	-432.0%	-85.83%
Net Earnings / Revenue	-46.99%	14.44%	-7.99%
Basic Earnings Per Share		$0.01	$0.00
Diluted Earnings Per Share	-$0.03	$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	85.79M shares	85.55M shares	79.53B shares
Diluted Shares Outstanding		85.64M shares	79.53B shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.43M	$27.36M	$19.93M
YoY Change	13.5%	37.31%	137.72%
Cash & Equivalents	$29.43M	$27.36M	$19.93M
Short-Term Investments
Other Short-Term Assets	$249.0K	$316.0K	$361.0K
YoY Change	-23.62%	-12.47%	64.84%
Inventory
Prepaid Expenses
Receivables	$2.430M	$2.681M	$1.520M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$32.11M	$30.36M	$21.81M
YoY Change	14.52%	39.21%	128.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$80.22M	$70.39M	$64.99M
YoY Change	20.38%	8.31%	-27.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.783M	$3.722M	$3.553M
YoY Change	6.77%	4.76%	0.08%
Total Long-Term Assets	$84.00M	$74.11M	$68.54M
YoY Change	19.69%	8.12%	-26.43%
TOTAL ASSETS
Total Short-Term Assets	$32.11M	$30.36M	$21.81M
Total Long-Term Assets	$84.00M	$74.11M	$68.54M
Total Assets	$116.1M	$104.5M	$90.35M
YoY Change	18.21%	15.63%	-12.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.556M	$719.0K	$752.0K
YoY Change	-40.75%	-4.39%	37.73%
Accrued Expenses	$13.84M	$1.820M	$483.0K
YoY Change	851.51%	276.81%	13.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$16.96M	$3.656M	$2.479M
YoY Change	227.39%	47.48%	21.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$2.689M	$2.080M	$1.954M
YoY Change	72.7%	6.45%	-12.73%
Total Long-Term Liabilities	$2.689M	$2.080M	$1.954M
YoY Change	72.7%	6.45%	-18.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.96M	$3.656M	$2.479M
Total Long-Term Liabilities	$2.689M	$2.080M	$1.954M
Total Liabilities	$19.65M	$5.736M	$4.433M
YoY Change	191.64%	29.39%	0.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$126.7M	-$124.0M	-$128.1M
YoY Change	-2.19%	-3.24%
Common Stock	$86.00K	$86.00K	$80.00K
YoY Change	2.38%	7.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$96.46M	$98.73M	$85.92M
YoY Change
Total Liabilities & Shareholders Equity	$116.1M	$104.5M	$90.35M
YoY Change	18.21%	15.63%	-12.03%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.784M	$1.079M	-$325.0K
YoY Change	88.49%	-432.0%	-85.83%
Depreciation, Depletion And Amortization	$4.726M	$2.313M	$1.666M
YoY Change	85.26%	38.84%	-43.98%
Cash From Operating Activities	$2.987M	$5.863M	$1.498M
YoY Change	49.42%	291.39%	-1449.55%
INVESTING ACTIVITIES
Capital Expenditures	$839.0K	-$1.366M	-$907.0K
YoY Change	-134.22%	50.61%	-47.14%
Acquisitions
YoY Change
Other Investing Activities	-$14.00K	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$853.0K	-$1.366M	-$907.0K
YoY Change	-65.21%	50.61%	-47.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-15.00K	0.000	0.000
YoY Change	-100.23%
NET CHANGE
Cash From Operating Activities	2.987M	5.863M	1.498M
Cash From Investing Activities	-853.0K	-1.366M	-907.0K
Cash From Financing Activities	-15.00K	0.000	0.000
Net Change In Cash	2.119M	4.497M	591.0K
YoY Change	-64.71%	660.91%	-132.35%
FREE CASH FLOW
Cash From Operating Activities	$2.987M	$5.863M	$1.498M
Capital Expenditures	$839.0K	-$1.366M	-$907.0K
Free Cash Flow	$2.148M	$7.229M	$2.405M
YoY Change	-51.74%	200.58%	49.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8303000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001141197
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84263146	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84263146	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.17
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35922
	dei	Entity Registrant Name EntityRegistrantName	PEDEVCO Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3755993
	dei	Entity Address Address Line1 EntityAddressAddressLine1	575 N. Dairy Ashford
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
	dei	City Area Code CityAreaCode	713
	dei	Local Phone Number LocalPhoneNumber	221-1768
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	PED
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85790267	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27361000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25930000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	2681000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1782000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	316000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	326000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	30358000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	28038000	usd
CY2022Q3	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	69699000	usd
CY2021Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	63908000	usd
CY2022Q3	us-gaap	Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative	592000	usd
CY2021Q4	us-gaap	Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative	2559000	usd
CY2022Q3	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	70291000	usd
CY2021Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	66467000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	98000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3722000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3543000	usd
CY2022Q3	us-gaap	Assets Assets	104469000	usd
CY2021Q4	us-gaap	Assets Assets	98221000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2626000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1454000	usd
CY2021Q4	ped	Revenue Payable Current RevenuePayableCurrent	938000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	49000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5181000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	81000	usd
CY2022Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2080000	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	1476000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	5736000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6738000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85790267	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84263146	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	84000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	222604000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	220984000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123957000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-129585000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	98733000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	91483000	usd
CY2022Q3	ped	Oil And Gas Sales OilAndGasSales	7472000	usd
CY2021Q3	ped	Oil And Gas Sales OilAndGasSales	4069000	usd
	ped	Oil And Gas Sales OilAndGasSales	24109000	usd
	ped	Oil And Gas Sales OilAndGasSales	11340000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	2918000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	1423000	usd
	us-gaap	Lease Cost LeaseCost	8076000	usd
	us-gaap	Lease Cost LeaseCost	4164000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1220000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1337000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4108000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4434000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2313000	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1666000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6427000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	6451000	usd
	us-gaap	Operating Expenses OperatingExpenses	13427000	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	0	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	1805000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1021000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-357000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	5498000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-282000	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	usd
	ped	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	0	usd
	us-gaap	Interest Expense InterestExpense	1000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	33000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	40000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000	usd
CY2022Q3	us-gaap	Other Income OtherIncome	25000	usd
CY2021Q3	us-gaap	Other Income OtherIncome	28000	usd
	us-gaap	Other Income OtherIncome	90000	usd
	us-gaap	Other Income OtherIncome	76000	usd
CY2022Q3	ped	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	0	usd
	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	0	usd
	ped	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPppLoan	374000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	58000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	130000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	460000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1079000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-325000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5628000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	85644180	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	79533016	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	85419689	shares
	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	78628077	shares
CY2022Q3	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	85644180	shares
CY2021Q3	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	79533016	shares
	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	85419689	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	78700140	shares
	us-gaap	Profit Loss ProfitLoss	-5628000	usd
	us-gaap	Profit Loss ProfitLoss	-178000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6427000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4829000	usd
	ped	Gain On Sale Of Oil And Gas Properties GainOnSaleOfOilAndGasProperties	0	usd
	ped	Gain On Sale Of Oil And Gas Properties GainOnSaleOfOilAndGasProperties	-1805000	usd
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	75000	usd
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	72000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1572000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1867000	usd
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	0	usd
	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	374000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	899000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	860000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-10000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	295000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-243000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	366000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	184000	usd
	ped	Increase Decrease Revenue Payable IncreaseDecreaseRevenuePayable	58000	usd
	ped	Increase Decrease Revenue Payable IncreaseDecreaseRevenuePayable	124000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12994000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3971000	usd
	ped	Cash Paid For Drilling Costs CashPaidForDrillingCosts	11413000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35000	usd
	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	1871000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11413000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-309000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	50000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	8237000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8237000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1631000	usd
	ped	Cash Paid For Drilling Costs CashPaidForDrillingCosts	2145000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11899000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29227000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11324000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30858000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23223000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	1791000	usd
	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	54000	usd
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	158000	usd
	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	16000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	91483000	usd
CY2022Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	563000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1339000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	93385000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	3210000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	97182000	usd
CY2022Q3	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	472000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	1079000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	98733000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	75636000	usd
CY2021Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2021Q1	ped	Stock Rescinded During Period Value StockRescindedDuringPeriodValue	0	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	684000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	728000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	85351000	usd
CY2021Q2	ped	Offering Costs Incurred For Issuance Of Common Stock To Non Affiliate OfferingCostsIncurredForIssuanceOfCommonStockToNonAffiliate	-66000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	591000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-225000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	85651000	usd
CY2021Q3	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	592000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	85918000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4069000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	24109000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11340000	usd
CY2022Q3	us-gaap	Cash Cash	27361000	usd
CY2021Q4	us-gaap	Cash Cash	25930000	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3497000	usd
CY2021Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3297000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	30858000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	29227000	usd
CY2021Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	151338000	usd
CY2022Q3	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	162927000	usd
CY2021Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	2559000	usd
CY2022Q3	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	592000	usd
CY2021Q4	ped	Asset Retirement Costs AssetRetirementCosts	789000	usd
CY2022Q3	ped	Asset Retirement Costs AssetRetirementCosts	947000	usd
CY2021Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	88219000	usd
CY2022Q3	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	94175000	usd
CY2021Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	66467000	usd
CY2022Q3	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	70291000	usd
	ped	Capital Costs Incurred Recently Completed Wells CapitalCostsIncurredRecentlyCompletedWells	9622000	usd
	ped	Cash Consideration During The Period CashConsiderationDuringThePeriod	500000	usd
	us-gaap	Recapitalization Costs RecapitalizationCosts	1200000	usd
	us-gaap	Acquisition Costs AcquisitionCosts	443000	usd
	ped	Total Acquisition And Due Diligence Costs TotalAcquisitionAndDueDiligenceCosts	534000	usd
CY2022Q3	us-gaap	Depletion Depletion	2084000	usd
CY2021Q3	us-gaap	Depletion Depletion	1576000	usd
	us-gaap	Depletion Depletion	5956000	usd
	us-gaap	Depletion Depletion	4520000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1525000	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	450000	usd
	ped	Liabilities Settled LiabilitiesSettled	-42000	usd
	ped	Changes In Estimates ChangesInEstimates	158000	usd
CY2022Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2091000	usd
CY2021Q4	ped	Cureent Asset Retirement CureentAssetRetirement	49000	usd
CY2022Q3	ped	Cureent Asset Retirement CureentAssetRetirement	11000	usd
	us-gaap	Other Expenses OtherExpenses	10000	usd
	ped	Supplemental Information Related To Operating Leasetabletextblock SupplementalInformationRelatedToOperatingLeasetabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td/><td/><td colspan="3" style="BORDER-BOTTOM: #000000 1px solid;width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">91</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	91000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	98000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	110000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	110000	usd
	ped	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P0Y10M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0535	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	82000	usd
CY2022Q3	ped	Lessee Operating Lease Liability Payments Due After Year Two LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo	0	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	30000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	112000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	110000	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	In the Permian Basin Asset, 63 acres are due to expire during the remainder of 2022 and 106 net acres expire thereafter (net to our direct ownership interest only)
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1440000	shares
CY2022Q2	ped	Shares Of Common Stock SharesOfCommonStock	87121	shares
CY2022Q2	ped	Sales Price Of Share SalesPriceOfShare	1.66
CY2022Q2	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	141000	usd
CY2021Q4	ped	Reimbursement Of Gross Proceeds ReimbursementOfGrossProceeds	4000	usd
CY2022Q2	us-gaap	Legal Fees LegalFees	91000	usd
CY2021Q4	ped	Sales Agent Commission SalesAgentCommission	0.03	pure
CY2022Q2	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	40000	usd
CY2021Q4	ped	Reimbursement Of Certain Specified Expenses ReimbursementOfCertainSpecifiedExpenses	25000	usd
CY2021Q4	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	3500000	usd
CY2022Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	520000	shares
CY2022Q1	us-gaap	Contract Termination Claims Description ContractTerminationClaimsDescription	The options have a term of five years and fully vest on January 2025, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	454000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.0156	pure
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.20	pure
CY2022Q3	ped	Company Recognized Stock Option Expense Debtissuance CompanyRecognizedStockOptionExpenseDebtissuance	312000	usd
CY2022Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	318000	usd
CY2022Q3	ped	Intrinsic Value Of Outstanding And Exercisable Options IntrinsicValueOfOutstandingAndExercisableOptions	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1123435	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	520000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.17
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	187435	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.34
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1456000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.51
	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P2Y9M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	624000	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1079000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-325000	usd
	us-gaap	Net Income Loss NetIncomeLoss	5628000	usd
	us-gaap	Net Income Loss NetIncomeLoss	178000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85644180	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79533016	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85419689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78628077	shares
	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
	us-gaap	Dilutive Securities DilutiveSecurities	72063000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85644180	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79533016	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85419689	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78700140	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1143436	shares
CY2022Q3	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1456000	shares
CY2022Q3	ped	Aggregate Civil Penalties AggregateCivilPenalties	850500	usd
CY2022Q3	ped	Interest Incurred On Unpaid Portions InterestIncurredOnUnpaidPortions	0.0875	pure
CY2022Q3	ped	Minimum Current Estimated Cost Of Well MinimumCurrentEstimatedCostOfWell	50000	usd

Files In Submission

Name	View Source	Status
0001654954-22-015283-index-headers.html	Edgar Link	pending
0001654954-22-015283-index.html	Edgar Link	pending
0001654954-22-015283.txt	Edgar Link	pending
0001654954-22-015283-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ped-20220930.xsd	Edgar Link	pending
ped_10q.htm	Edgar Link	pending
ped_10qimg1.jpg	Edgar Link	pending
ped_ex311.htm	Edgar Link	pending
ped_ex312.htm	Edgar Link	pending
ped_ex321.htm	Edgar Link	pending
ped_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
ped-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ped-20220930_def.xml	Edgar Link	unprocessable
ped-20220930_pre.xml	Edgar Link	unprocessable
ped_10q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ped-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PED
PEDEVCO CORP Stock $ped

2022 Q4 Form 10-Q Financial Statement

#000165495422015283 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED PEDEVCO CORP Stock $ped

2022 Q4 Form 10-Q Financial Statement

#000165495422015283 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED
PEDEVCO CORP Stock $ped